122 related articles for article (PubMed ID: 11427452)
1. Development of a dual monoclonal antibody immunoassay for total human kallikrein 2.
Finlay JA; Day JR; Evans CL; Carlson R; Kuus-Reichel K; Millar LS; Mikolajczyk SD; Goodmanson M; Klee GG; Rittenhouse HG
Clin Chem; 2001; 47(7):1218-24. PubMed ID: 11427452
[TBL] [Abstract][Full Text] [Related]
2. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
[TBL] [Abstract][Full Text] [Related]
3. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2.
Klee GG; Goodmanson MK; Jacobsen SJ; Young CY; Finlay JA; Rittenhouse HG; Wolfert RL; Tindall DJ
Clin Chem; 1999 Jun; 45(6 Pt 1):800-6. PubMed ID: 10351988
[TBL] [Abstract][Full Text] [Related]
5. Development of sensitive immunoassays for free and total human glandular kallikrein 2.
Väisänen V; Eriksson S; Ivaska KK; Lilja H; Nurmi M; Pettersson K
Clin Chem; 2004 Sep; 50(9):1607-17. PubMed ID: 15247158
[TBL] [Abstract][Full Text] [Related]
6. Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.
Becker C; Piironen T; Kiviniemi J; Lilja H; Pettersson K
Clin Chem; 2000 Feb; 46(2):198-206. PubMed ID: 10657376
[TBL] [Abstract][Full Text] [Related]
7. Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Steuber T; Vickers AJ; Serio AM; Vaisanen V; Haese A; Pettersson K; Eastham JA; Scardino PT; Huland H; Lilja H
Clin Chem; 2007 Feb; 53(2):233-40. PubMed ID: 17185368
[TBL] [Abstract][Full Text] [Related]
8. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
[TBL] [Abstract][Full Text] [Related]
9. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Magklara A; Scorilas A; Catalona WJ; Diamandis EP
Clin Chem; 1999 Nov; 45(11):1960-6. PubMed ID: 10545066
[TBL] [Abstract][Full Text] [Related]
10. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
11. Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.
Partin AW; Catalona WJ; Finlay JA; Darte C; Tindall DJ; Young CY; Klee GG; Chan DW; Rittenhouse HG; Wolfert RL; Woodrum DL
Urology; 1999 Nov; 54(5):839-45. PubMed ID: 10565744
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum.
Piironen T; Lövgren J; Karp M; Eerola R; Lundwall A; Dowell B; Lövgren T; Lilja H; Pettersson K
Clin Chem; 1996 Jul; 42(7):1034-41. PubMed ID: 8674186
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.
Corey E; Buhler KR; Vessella RL
Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733
[TBL] [Abstract][Full Text] [Related]
14. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
[TBL] [Abstract][Full Text] [Related]
15. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
16. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
[TBL] [Abstract][Full Text] [Related]
17. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
[TBL] [Abstract][Full Text] [Related]
18. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.
Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS
Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742
[TBL] [Abstract][Full Text] [Related]
19. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.
Charlesworth MC; Young CY; Klee GG; Saedi MS; Mikolajczyk SD; Finlay JA; Tindall DJ
Urology; 1997 Mar; 49(3):487-93. PubMed ID: 9123724
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1.
Finlay JA; Day JR; Rittenhouse HG
Urology; 1999 Apr; 53(4):746-51. PubMed ID: 10197850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
